Skip to main content
New Menu
Technology
Pharma
Clinical
Clinical Trials
Publications
About Us
Team
Press Releases
Blog
Articles
Collaborators
Videos
Careers
Portal
New Menu
Technology
Pharma
Clinical
Clinical Trials
Publications
About Us
Team
Press Releases
Blog
Articles
Collaborators
Videos
Careers
Portal
Technology
Pharma
Clinical
Overview
Clinical Trials
Publications
About Us
Overview
Team
Press Releases
Blog
Articles
Collaborators
Videos
Careers
Portal
Publications
Breadcrumb
Cellworks
Publications
PUBLICATIONS
Browse by Indication
All
Acute Myeloid Leukemia
Esophageal Cancer
Colorectal Cancer
Glioblastoma Multiforme
Head and Neck Cancer
Kidney Cancer
Liver Cancer
Melanoma
Myelodysplastic Syndrome
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
Pancreatic Cancer
Browse by Study Type or Conference
All
Model Validation
Clinical Validation
AACR
ASCO
ASH
WCLC
ESMO
Browse by Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
ARCHIVE
Assessment of Cellworks Omics Biosimulation Therapy Response Predictions for Patients with Acute Myeloid Leukemia (AML) Using Cellworks Singula™: myCare-020-01
Blood Journal,
2020
Superior Therapy Response Predictions for Patients with Myelodysplastic Syndrome (MDS) Using Cellworks Singula™: myCare-020-02
Blood Journal,
2020
Predicting Resistance to the Combination of ATO and ATRA in APL Patients with PML-Rara Fusions, Using a Computational Biology Modeling Approach
Blood Journal,
2020
Prediction of Clinical Response for Frontline Treatment of Acute Myeloid Leukemia (AML) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-02
Blood Journal,
2020
Comparative Analysis for Differential Drug Response between Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) and T-Cell Acute Lymphoblastic Leukemia (T-ALL) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-03
Blood Journal,
2020
Monosomy 7 and Co-Occurrent Genomic Aberrations Determine Chemotherapy Response in Acute Myeloid Leukemia (AML) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-04
Blood Journal,
2020
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
The Lancet Oncology,
2020
Superior therapy response predictions for patients with acute myeloid leukemia (AML) using Cellworks Singula: MyCare-009-01
ASCO Meeting Library,
2020
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Page
2
Page
3
Current page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next ›
Last page
Last »
Technology
Pharma
Clinical
Overview
Clinical Trials
Publications
About Us
Overview
Team
Press Releases
Blog
Articles
Collaborators
Videos
Careers
Portal
STAY INFORMED
Top